Covering SB without PCI SB (n = 64, group A) | N | Covering SB + PCI SB (n = 34, group B) | N | Difference | CI; P | |
---|---|---|---|---|---|---|
3-vessel disease (no., percent) | 19 (29.7%) | 64 | 13 (38.2) | 34 | 1.47a | (0.61; 3.52) 0.39 |
Ejection fraction (%: mean, range, standard deviation) | 53.4% (20–70; 11.5) | 64 | 55.7 (40–65; 8.9) | 34 | −2.4b | (−7.4; 2.7) 0.35 |
Visible thrombus (no, percent) | 10 (15.6%) | 64 | 8 ( 23.5%) | 34 | 1.63 | (0.58; 4.62) 0.36 |
Bifurcation localization: LM (no., percent) | 4 (6.3%) | 64 | 1 (2.9%) | 34 | 0.62a | (0.06; 6.16) 0.68 |
Bifurcation localization: LAD/SB (no., percent) | 38 (59.4%) | 64 | 19 (55.9%) | 34 | 0.87a | (0.37; 2.01) 0.74 |
Bifurcation localization: LCX/SB (no., percent) | 15 (23.4%) | 64 | 9 (26.5%) | 34 | 1.18a | (0.45; 3.06) 0.74 |
Bifurcation localization: RCA/SB (no., percent) | 7 (10.9%) | 64 | 5 (14.7%) | 34 | 1.40a | (0.41; 4.81) 0.59 |